Increased asymmetric dimethylarginine (ADMA) levels and insulin resistance in non-diabetic stage I kidney disease

被引：0
作者：
Yilmaz, Mahmut Ilker
Caglar, Kayser
Sonmez, Alper
Cakir, Erdinc
Kaya, Ayper
Acikel, Cengizhan
Eyileten, Tayfun
Yenicesu, Mujdat
Oguz, Yusuf
Bilgi, Cumhur
Oktenli, Cagatay
Vural, Abdulgaffar
Zoccali, Carmine
机构：
[1] Gulhane Sch Med, Ankara, Turkey
[2] CNR, IBIM, Reggio Di Calabria, Italy
[3] Inst Biomed Clin Epidemiol & Pathophysiol Renal D, Reggio Di Calabria, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2006年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：63 / 63
页数：1
相关论文
共 50 条
  • [21] Asymmetric dimethylarginine (ADMA) and carotid atherosclerosis in end-stage renal disease
    Mallamaci, F
    Benedetto, F
    Tripepi, G
    Malatino, L
    Boeger, R
    Zoccali, C
    JOURNAL OF HYPERTENSION, 2002, 20 : S140 - S140
  • [22] Insulin resistance and muscle wasting in non-diabetic end-stage renal disease patients
    Lee, Seoung Woo
    Park, Geun Ho
    Lee, Seung Won
    Song, Joon Ho
    Hong, Kee Chun
    Kim, Moon-Jae
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (09) : 2554 - 2562
  • [23] Metabolic syndrome, insulin resistance and kidney function in non-diabetic individuals
    Johns, Barry R.
    Pao, Alan C.
    Kim, Sun H.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (04) : 1410 - 1415
  • [24] Insulin resistance in non-diabetic people with Parkinson's disease
    Tagliati, M.
    Tan, E.
    Eskenazi, J.
    Basile, C.
    Hogg, E.
    MOVEMENT DISORDERS, 2017, 32
  • [25] Increased Plasma Levels of Asymmetric Dimethylarginine in Nonalcoholic Fatty Liver Disease: Relation With Insulin Resistance, Inflammation, and Liver Histology
    Boga, Salih
    Alkim, Huseyin
    Koksal, Ali Riza
    Bayram, Mehmet
    Ozguven, Muveddet Banu Yilmaz
    Ergun, Meltem
    Neijmann, Sebnem Tekin
    Ozgon, Gulay
    Alkim, Canan
    JOURNAL OF INVESTIGATIVE MEDICINE, 2015, 63 (07) : 871 - 877
  • [26] Increased asymmetric dimethylarginine (ADMA) levels and decreased homocysteine thiolactonase/paraoxonase (HTLase/PONase) activities are related to the risk of cardiovascular disease in prediabetic/diabetic patients
    Bayrak, Tulin
    Bayrak, Ahmet
    Isildak, Mehlika
    Cakir, Erdinc
    Gurlek, Alper
    Akbiyik, Filiz
    TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, 2014, 39 (03): : 270 - 276
  • [27] Unchanged asymmetric dimethylarginine levels in non-diabetic, premenopausal obese women who have common risk factors for cardiovascular disease
    Cetinalp-Demircan, P.
    Can, A.
    Bekpinar, Selda
    Unlucerci, Y.
    Orhan, Y.
    ENDOCRINE, 2007, 31 (02) : 100 - 104
  • [28] Unchanged asymmetric dimethylarginine levels in non-diabetic, premenopausal obese women who have common risk factors for cardiovascular disease
    P. Cetinalp-Demircan
    A. Can
    Selda Bekpinar
    Y. Unlucerci
    Y. Orhan
    Endocrine, 2007, 31 : 100 - 104
  • [29] Asymmetric dimethylarginine (ADMA) accelerates progression of chronic kidney disease by enhancing capillary rarefaction
    Matsumoto, Yuriko
    Ueda, Seiji
    Yamagishi, Sho-ichi
    Matsuguma, Kyoko
    Miyazaki, Hiroshi
    Aoyagi, Fumiko
    Okuda, Seiya
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 6 - 6
  • [30] ASYMMETRIC DIMETHYLARGININE (ADMA) AND PROGRESSION OF CHRONIC KIDNEY DISEASE: THE MILD TO MODERATE KIDNEY FAILURE (MMKF) STUDY
    Kielstein, Jan T.
    Kronenberg, Florian
    Fliser, Danilo
    Bode-Boeger, Stefanie M.
    Ritz, Eberhardt
    NEPHROLOGY, 2005, 10 : A236 - A236
12345